What's happening
This bill prohibits insurance companies from charging co-payments for treatments at opioid treatment programs in New York.
Why it matters
Reduces financial barriers to opioid addiction treatment. by ensuring patients can access medication-assisted therapy without additional out-of-pocket costs, potentially leading to better treatment adherence and recovery rates.
Targets insurance practices that may discourage ongoing care. , as co-payments can add up over time for those requiring daily or frequent visits to opioid treatment programs.
Standardizes coverage across all types of health insurance regulated in New York. , creating consistent protections for individuals with opioid use disorder, regardless of their insurance provider.
May contribute to broader public health goals. by making evidence-based opioid treatment more accessible, which can help reduce overdose rates and associated social and economic costs.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
End Opioid Treatment Co-Pays
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Substituted by A372
- Advanced to third reading
- 2nd report cal.
- 1st report cal.763
- Referred to insurance
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
End Opioid Treatment Co-Pays
Signed by Governor · Sponsor Linda Rosenthal
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
5690
2021-2022 Regular Sessions
IN SENATE
March 16, 2021
Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance
AN ACT to amend the insurance law, in relation to prohibiting co-payments for treatment at an opioid treatment program
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 31-b to read as follows:
(31-b) Every policy that provides coverage for treatment at an opioid treatment program shall not impose a co-payment fee during the course of treatment on any insured for such treatment. For the purposes of this section "opioid treatment program" means a program or practitioner engaged in opioid treatment of individuals with an opioid agonist treatment medication.
§ 2. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 7-b to read as follows:
(7-b) Every policy that provides coverage for treatment at an opioid treatment program shall not impose a co-payment fee during the course of treatment on any insured for such treatment. For the purposes of this section "opioid treatment program" means a program or practitioner engaged in opioid treatment of individuals with an opioid agonist treatment medication.
§ 3. Section 4303 of the insurance law is amended by adding a new subsection (l-2) to read as follows:
(l-2) Every policy that provides coverage for treatment at an opioid treatment program shall not impose a co-payment fee during the course of treatment on any insured for such treatment. For the purposes of this section "opioid treatment program" means a program or practitioner engaged in opioid treatment of individuals with an opioid agonist treatment medication.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00586-01-1
S. 5690 2
§ 4. This act shall take effect on the first of January next succeeding the date on which it shall have become a law and shall apply to policies and contracts issued, renewed, modified, altered or amended on and after such date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the insurance law, in relation to prohibiting co-pay- ments for treatment at an opioid treatment program
Purpose
This bill relates to prohibiting co-payments for treatment at an opioid treatment program during course of treatment.
Summary of specific provisions
Section one amends the insurance law by adding a new paragraph 31-b to section 3216 Section two amends the insurance law by adding a new para- graph 7-c to section 3221 Section three amends the insurance law by adding a subsection (1-2) to section 4303.
Section four sets forth the effective date.
Justification
Private insurance plans, including plans available under the Affordable Care Act, require co-pays to be collected every time a patient visits an Opioid Treatment Program (OTP). This requirement does not take into account the frequency of patient visits, and creates a barrier to OTP treatment services. At the start of treatment, patients are required by federal law to receive treatment up to 6 times a week for 90 days. Once those 90 days are up, many patients continue to seek treatment several times a week. Requiring daily co-pays under these circumstances becomes cost-prohibitive for people seeking treatment. Prohibiting co-payments for treatment at an OTP will help all New Yorkers in need to gain access to potentially lifesaving services.
Legislative history
2019-20: A.972-A - Passed Assembly; S.4643-A - Referred to Insurance
2017-18: A.9082 - Referred to Insurance
Fiscal implications
Undetermined.
Effective date
This bill shall take effect on the first of January next succeeding the date on which it shall have become a law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.